These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Recurrent genital herpes].
    Author: Holub M, Labská K, Roubalová K.
    Journal: Klin Mikrobiol Infekc Lek; 2008 Apr; 14(2):52-9. PubMed ID: 18756434.
    Abstract:
    In recent years, the rate of genital infections caused by Herpes simplex virus types 1 and 2 (HSV-1, HSV-2) has increased. Following primary infection with HSV-2, recurrent genital herpes (GH) often develops or asymptomatic virus shedding occurs. HSV-1-induced GH recurrencies are significantly less frequent. The options for diagnosing HSV infections have improved markedly: they include determination of type-specific antibodies in the blood (anti-HSV-1 and anti-HSV-2), culture of HSV from lesions or detection of viral antigens by immunohistochemistry methods; it is also possible to detect viral DNA by polymerase chain reaction. At present, recurrent genital herpes is treated by the so-called episodic therapy or suppressor antiviral therapy, in the Czech Republic based on acyclovir or valacyclovir. Preventive measures are possible only to a limited extent, particular attention is paid to pregnant women and the risk of disseminated herpes infection in newborns. New preventive and therapeutic options continue to be developed: a preventive vaccine against HSV-2 has been successfully tested, but this is effective only in HSV-1 negative women; experimental therapeutic vaccination stimulating specific immunity has not yet been successful.
    [Abstract] [Full Text] [Related] [New Search]